← Back to Search

2 for Lupus

Phase 2
Waitlist Available
Led By Ronald T. Brown, PhD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Diagnosis of systemic lupus erythematosus (SLE)
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This study will evaluate a program designed to help African American adolescents with lupus (systemic lupus erythematosus or SLE) cope with the disease.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: 2Experimental Treatment1 Intervention
Group receiving coping intervention designed to enhance coping and psychological adjustment
Group II: 3Active Control1 Intervention
Comparison control group with no active intervention
Group III: 1Active Control1 Intervention
Educational comparison group
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Coping skills and cognitive restructuring techniques
2004
Completed Phase 2
~120

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
972 Previous Clinical Trials
7,399,182 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
496 Previous Clinical Trials
1,089,392 Total Patients Enrolled
1 Trials studying Lupus
150 Patients Enrolled for Lupus
Ronald T. Brown, PhDPrincipal InvestigatorDepartment of Public Health - Temple University
~6 spots leftby Nov 2025